Systematic Review
Published on 18 Mar 2021
Biologic Drug Survival in Psoriasis: A Systematic Review & Comparative Meta-Analysis
in Dermatology
Frontiers in Medicine
doi 10.3389/fmed.2020.625755
- 11,096 views
- 42 citations
18 articles related to "Drug Survival"
Articles
Brief Research Report
Published on 11 Jan 2024
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2023.1341708
- 12,969 views
- 46 citations
Original Research
Published on 23 May 2024
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR database
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2024.1395968
- 5,122 views
- 8 citations
Original Research
Published on 08 Jan 2019
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2018.01526
- 5,834 views
- 10 citations
Original Research
Published on 08 Dec 2025
A 20-year real-world study on drug survival and predictive factors for infliximab discontinuation in Behçet’s syndrome
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2025.1726690
- 1,452 views
Original Research
Published on 21 Jul 2021
Switching and Discontinuation Pattern of Biologic Disease-Modifying Antirheumatic Drugs and Tofacitinib for Patients With Rheumatoid Arthritis in Taiwan
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.628548
- 9,165 views
- 15 citations
Hypothesis and Theory
Published on 05 May 2020
MarA, RamA, and SoxS as Mediators of the Stress Response: Survival at a Cost
in Antimicrobials, Resistance and Chemotherapy
Frontiers in Microbiology
doi 10.3389/fmicb.2020.00828
- 10,347 views
- 52 citations
Perspective
Published on 07 Apr 2020
What Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2020.00589
- 11,782 views
- 33 citations
Original Research
Published on 24 Oct 2025
Comparative real-world effectiveness and safety of biologics and JAK inhibitors in atopic dermatitis: short- and medium-to-long-term analysis from a regional healthcare network in southern Spain
in Dermatology
Frontiers in Medicine
doi 10.3389/fmed.2025.1658843
- 3,857 views
- 1 citation
Original Research
Published on 13 Jan 2022
Association of Gender, Diagnosis, and Obesity With Retention Rate of Secukinumab in Spondyloarthropathies: Results Form a Multicenter Real-World Study
in Rheumatology
Frontiers in Medicine
doi 10.3389/fmed.2021.815881
- 4,746 views
- 23 citations
Original Research
Published on 03 Jul 2023
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)
in Dermatology
Frontiers in Medicine
doi 10.3389/fmed.2023.1196966
- 5,850 views
- 29 citations
Original Research
Published on 23 Aug 2019
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00918
- 5,991 views
- 36 citations
Original Research
Published on 26 May 2021
Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
in Rheumatology
Frontiers in Medicine
doi 10.3389/fmed.2021.679009
- 7,146 views
- 49 citations
Original Research
Published on 04 Jan 2023
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Frontiers in Immunology
doi 10.3389/fimmu.2022.1074044
- 9,421 views
- 20 citations
Systematic Review
Published on 05 Apr 2022
Efficacy of Systemic Biologic Drugs in Pediatric Psoriasis: Evidence From Five Selected Randomized Clinical Trials
in Obstetric and Pediatric Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.847308
- 5,987 views
- 8 citations
Original Research
Published on 03 Oct 2022
Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2022.980832
- 3,902 views
- 9 citations